Citations 383
Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis
Gardner, Lindsay B., Moustafa, Mohamad Alhaj, Sher, Taimur , Rasheed, Ahsan , Warsame, Rahma , Larsen, Jeremy T. , Kourelis, Taxiarchis , Kapoor, Prashant , Chanan‐Khan, Asher , Parrondo, Ricardo D , Roy, Vivek , Gonsalves, Wilson I. , Fonseca, Rafaël , Ailawadhi, Sikander
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7237-7238
Time-Limited Maintenance with Ibrutinib after First-Line Therapy and the Incremental Impact on Minimal Residual Disease (MRD) for Patients with Chronic Lymphocytic Leukemia (CLL)
Paulus, Aneel , LaPlant, Betsy, Alegria, Victoria R., Zimmerman, Ashley, Chapin, Dustin, Sher, Taimur , Chanan‐Khan, Asher , Paulus, Aneel , Ailawadhi, Sikander , Parrondo, Ricardo D , Roy, Vivek
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9904-9905
Phase II Study of Ibrutinib in Combination with Ixazomib in Patients with Waldenström Macroglobulinemia (WM)
LaPlant, Betsy, Alegria, Victoria R., Elliott, Jamie, Zimmerman, Ashley, Heslop, Keisha, Chapin, Dustin, Sher, Taimur , Rasheed, Ahsan , Paulus, Aneel , Chanan‐Khan, Asher , Paulus, Aneel , Ailawadhi, Sikander , Parrondo, Ricardo D , Roy, Vivek
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9331-9332
Real-World Assessment of Second Primary Malignancies in a Treated and Untreated Chronic Lymphocytic Leukemia Population in the United States
Ravelo, Arliene , Ng, Carmen, Shah, Bonny, Wang, Rongrong , Eakle, Katherine, Biondo, Juliana M.L., Ailawadhi, Sikander
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8040-8041
Impact of COVID-19 on Treatment Patterns and Management of Multiple Myeloma: Insights from the Connect® MM Registry
Terebelo, Howard R. , Abonour, Rafat , Durie, Brian G.M. , Omel, James L., Narang, Mohit , Toomey, Kathleen, Rifkin, Robert M. , Gasparetto, Cristina, Yu, Edward, Anand, Jasmeet, Liu, Liang , Jou, Ying‐Ming, Jagannath, Sundar, Richter, Joshua , Ailawadhi, Sikander , Lee, Hans C. , Hardin, James W. , Wagner, Lynne I. , Omel, James, Gasparetto, Cristina , Jagannath, Sundar
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8089-8091
Peri-Transplant and Maintenance Daratumumab for Minimal Residual Disease (MRD) Eradication in Transplant-Eligible Multiple Myeloma (MM) Patients
Pérez, Gabriela , Kharfan‐Dabaja, Mohamed A. , Ayala, Ernesto, O’Brien, Patrick, Alegria, Victoria R., Zimmerman, Ashley, Chapin, Dustin, Lanier, Stephanie, Kasik, Carly, Bradley, Schannon, Sher, Taimur , Paulus, Aneel , Chanan‐Khan, Asher , Paulus, Aneel , Ailawadhi, Sikander , Parrondo, Ricardo D , Murthy, Hemant S. , Roy, Vivek
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10165-10166
Renal Toxicity with Carfilzomib in Multiple Myeloma: Secondary Analysis of SWOG S1304 Comparing Low-Dose Versus High-Dose Carfilzomib
Sexton, Rachael, Lentzsch, Suzanne , Voorhees, Peter M. , Rohren, Eric , Kelly, Kevin R. , Mackler, Niklas J., Baer, David, Hoering, Antje , Durie, Brian G.M. , Chakraborty, Rajshekhar , Abidi, Muneer H. , Cohen, Adam D. , Heitner, Stephen B. , Ailawadhi, Sikander , Orlowski, Robert Z.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4349-4351
The CAR-Hematotox Score As a Prognostic Model of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma
Bansal, Radhika , Logue, Jennifer M., Freeman, Ciara L. , Alsina, Melissa , Lin, Yi , Subklewe, Marion , Rejeski, Kai , Hansen, Doris K. , Sesques, Pierre , Ailawadhi, Sikander , Logue, Jennifer M., Theurich, Sebastian , Locke, Frederick L. , Bachy, Emmanuel , Jain, Michael D.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7506-7508
Advancing CAR T-Cell Care in Relapsed/Refractory Multiple Myeloma: Insights from a Collaborative Quality Improvement Initiative
Sullivan, Shelby , Carter, Jeffrey D., Heggen, Cherilyn, Ailawadhi, Sikander , Sullivan, Shelby, Carter, Jeffrey D, Heggen, Cherilyn
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 5064-5065
Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination
Zanwar, Saurabh , Larsen, Jeremy T. , Chanan‐Khan, Asher , Hayman, Suzanne R. , Kapoor, Prashant , Kourelis, Taxiarchis , Lacy, Martha Q. , Lin, Yi , Sher, Taimur , Warsame, Rahma , Fonder, Amie , Hobbs, Miriam, Hwa, Yi L. , Kyle, Robert A. , Kumar, Shaji , Ho, Matthew , Buadi, Francis K. , Ailawadhi, Sikander , Bergsagel, P. Leif , Binder, Moritz , Dingli, David , Dispenzieri, Angela , Fonseca, Rafaël , Gertz, Morie A. , Gonsalves, Wilson I. , Go, Ronald S. , Leung, Nelson , Muchtar, Eli , Roy, Vivek , Rajkumar, S. Vincent
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10017-10019